Advisory panel to US FDA endorses emergency use of Pfizer vaccine
An advisory panel to the US Food and Drug Administration has endorsed emergency use of Pfizer and BioNTech's COVID-19 vaccine for mass vaccinations. The panel concluded that the shot appears safe and effective against COVID-19 in people aged 16 and above. If the FDA grants approval, the US will be the third country to authorise the use of the vaccine.